Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

2.01
+0.01000.50%
Post-market: 1.96-0.0500-2.49%19:39 EDT
Volume:2.06M
Turnover:4.28M
Market Cap:256.60M
PE:-1.22
High:2.30
Open:2.06
Low:1.94
Close:2.00
Loading ...

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
24 Feb

Prime Drink Group Announces The Appointment Of A New Chief Financial Officer

T-Reuters
·
14 Jan

Is Prime Medicine (PRME) Among the Top CRISPR Stocks to Invest In?

Insider Monkey
·
01 Jan

Why Prime Medicine (PRME) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024

Prime Medicine, Inc. (PRME): Is This Gene Therapy Stock a Good Buy Right Now?

Insider Monkey
·
29 Dec 2024

Prime Medicine Files for Resale of 11 Million Shares

MT Newswires Live
·
13 Dec 2024

Prime Medicine Inc Files for Resale of up to 11 Mln Common Shares by the Selling Stockholder - SEC Filing

THOMSON REUTERS
·
13 Dec 2024

JMP Securities Initiates Prime Medicine at Market Outperform With $10 Price Target

MT Newswires Live
·
10 Dec 2024

Prime Medicine Price Target Maintained With a $18.00/Share by Guggenheim

Dow Jones
·
04 Dec 2024

Prime Medicine, Inc. (PRME) Gets a Hold from Morgan Stanley

TIPRANKS
·
15 Nov 2024

Prime Medicine Is Maintained at Buy by Chardan Capital

Dow Jones
·
14 Nov 2024

Prime Medicine, Inc.: Strategic Initiatives and Promising Developments Drive Buy Rating

TIPRANKS
·
13 Nov 2024

Prime Medicine Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Nov 2024

Prime Medicine, Inc. Receives Buy Rating from Arthur He CFA: Strategic Partnerships and Pipeline Focus Drive Promising Future Prospects

TIPRANKS
·
13 Nov 2024

U.S. RESEARCH ROUNDUP- AMN Healthcare Services, Chart Industries, Home Depot

Reuters
·
13 Nov 2024

Prime Medicine Inc : Chardan Capital Markets Cuts Target Price to $15 From $17

THOMSON REUTERS
·
13 Nov 2024